Pluri Inc. (NASDAQ:PLUR – Get Free Report) shares traded down 2.8% on Wednesday . The stock traded as low as $4.33 and last traded at $4.45. 4,272 shares changed hands during mid-day trading, a decline of 77% from the average session volume of 18,389 shares. The stock had previously closed at $4.58.
Pluri Stock Down 2.8 %
The firm has a market capitalization of $24.74 million, a P/E ratio of -0.74 and a beta of 1.64. The company has a debt-to-equity ratio of 4.44, a quick ratio of 5.90 and a current ratio of 5.90. The stock has a 50 day moving average of $4.90 and a 200-day moving average of $5.26.
About Pluri
Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.
Featured Stories
- Five stocks we like better than Pluri
- What Are Trending Stocks? Trending Stocks Explained
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- What Are Dividend Contenders? Investing in Dividend Contenders
- 2 Drone Stocks Surging from Increased Media Attention
- What is a support level?
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Pluri Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pluri and related companies with MarketBeat.com's FREE daily email newsletter.
